Stock 300298 SINOCARE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Sinocare Inc.

Equities

300298

CNE100001CJ0

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
23.89 CNY -0.95% Intraday chart for Sinocare Inc. +3.11% -21.41%
04-26 Sinocare Inc. Proposes Final Dividend for 2023 CI
04-25 Sinocare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • With an expected P/E ratio at 31.85 and 22.48 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SINOCARE INC. Stock Sinocare Inc.
-21.41% 1.83B -
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.79% 184B
C+
MEDTRONIC PLC Stock Medtronic plc
-0.84% 107B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.75% 69.44B
A
DEXCOM, INC. Stock DexCom, Inc.
+3.45% 50.37B
B-
CENCORA, INC. Stock Cencora, Inc.
+9.04% 44.82B
B-
HOYA CORPORATION Stock Hoya Corporation
+3.40% 41.53B
B+
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.66% 26.84B
A-
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.21% 26.73B
B
TERUMO CORPORATION Stock Terumo Corporation
+15.23% 25.71B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 300298 Stock
  4. Ratings Sinocare Inc.